These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8796136)

  • 1. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
    Rodríguez-Arnao J; Perry L; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
    Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
    Al-Shoumer KA; Ali K; Anyaoku V; Niththyananthan R; Johnston DG
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children.
    Portes ES; Oliveira JH; MacCagnan P; Abucham J
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):183-9. PubMed ID: 10931099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults.
    Tschöp M; Lahner H; Feldmeier H; Grasberger H; Morrison KM; Janssen OE; Attanasio AF; Strasburger CJ
    Eur J Endocrinol; 2000 Dec; 143(6):769-73. PubMed ID: 11124860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
    Pfeifer M; Kanc K; Verhovec R; Kocijancic A
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.
    al-Shoumer KA; Beshyah SA; Niththyananthan R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum.
    Scriba PC; Bauer M; Emmert D; Fateh-Moghadam A; Hofmann GG; Horn K; Pickardt CR
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):629-43. PubMed ID: 115194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
    al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studies.
    Glynn N; Kenny H; Quisenberry L; Halsall DJ; Cook P; Kyaw Tun T; McDermott JH; Smith D; Thompson CJ; O'Gorman DJ; Boelen A; Lado-Abeal J; Agha A
    Clin Endocrinol (Oxf); 2017 May; 86(5):747-754. PubMed ID: 27809356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
    Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults.
    Beshyah SA; Shahi M; Skinner E; Sharp P; Foale R; Johnston DG
    Eur J Endocrinol; 1994 May; 130(5):451-8. PubMed ID: 8180671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ghrelin levels are suppressed in hypopituitary patients following insulin-induced hypoglycaemia irrespective of GH status.
    Ryber L; Obrink K; Houe N; Frystyk J; Jørgensen JO
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):210-4. PubMed ID: 16886962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.
    Jørgensen JO; Møller J; Laursen T; Orskov H; Christiansen JS; Weeke J
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):609-14. PubMed ID: 7828350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.